Cardiovascular Devices Market Size, Share & Trends Analysis Report By Product (Diagnostic & Monitoring (ECG, Holter), Surgical Devices (Pacemakers, Stents)), By Region, And Segment Forecasts, 2023 - 2030

Cardiovascular Devices Market Size, Share & Trends Analysis Report By Product (Diagnostic & Monitoring (ECG, Holter), Surgical Devices (Pacemakers, Stents)), By Region, And Segment Forecasts, 2023 - 2030


Cardiovascular Devices Market Growth & Trends

The global cardiovascular devices market size is anticipated to reach USD 83.56 billion by 2030, registering a CAGR of 7.1%, according to a new report by Grand View Research, Inc. Increasing geriatric population, sedentary life style coupled with unhealthy dietary habits is spurring the prevalence of cardiovascular diseases. Constant rise in the patients suffering from cardiovascular diseases and is expected to drive market growth during the forecast period.

Governments are trying to limit hospital readmissions to reduce the prevalence of hospital acquired infections (HAIs) by imposing penalties on hospitals. As a result, adoption of home healthcare, remote patient monitoring, and long term care services is rapidly increasing. Thus, demand for cardiovascular devices is increasing from hospitals, patients based in home settings, and long term care centers.

In addition, favorable government policies such as reimbursement coverage are fueling adoption of these devices. Thus, increasing target patient population, rising acceptance of home healthcare, and favorable government policies are some of the major factors driving the growth of the global cardiovascular devices market.

On the other hand, high device cost and stringent regulatory approval procedure are some of the prime factors challenging the growth of the market. In addition, lack of skilled professionals to perform surgical procedures using advanced devices is impeding the adoption of new devices.

Cardiovascular Devices Market Report Highlights
  • Availability of minimally invasive surgical devices coupled with high surgical cost is resulting in higher revenue share of surgical devices. As a result, surgical devices segment dominated the overall market in 2022
  • Diagnostics and monitoring device segment is anticipated to grow at the fastest growth rate of 7.6% during the forecast period. Government initiatives to promote early diagnosis of the diseases, increasing adoption of home healthcare services and long term care centers is primarily affecting the growth of diagnostic and monitoring segment positively.
  • North America dominated with market share of 35.0% of the global market in 2022. Presence of large pool of target population, reimbursement coverage and high adoption rate for advanced treatments are some of the factors driving the growth of the cardiovascular devices market in North America.
  • Furthermore, favorable government policies and presence of well-defined regulatory framework are some of the factors augmenting the market growth in North America.
  • Asia Pacific is anticipated to register significant growth during the forecast period. Growth of the region would primarily attribute to anticipated rise in geriatric population prone to cardiac diseases and booming medical tourism in Asia Pacific.
  • Moreover, presence of rapidly developing countries such as India and China are expected to render positive growth to the Asia Pacific market. Government initiatives to improve healthcare infrastructure, increasing healthcare expenditure and increasing demand for advanced healthcare facilities are some of the factors anticipated to push the market in India and China towards swift growth.
  • Major players contributing to the global market include, Medtronic plc, Becton Dickinson Competition among the key players would depend upon several factors included but not limited to manufacturing capacity, strong distribution network, pricing strategy and product innovation
Please note The report will be delivered in 4-8 business days upon order notification.


Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Product
1.1.2. Regional scope
1.1.3. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.5. Market Formulation & Validation
1.6. Model Details
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product outlook
2.2.2. Regional outlook
2.3. Competitive Insights
Chapter 3. Cardiovascular Devices Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Market Dynamics
3.3.1. Market driver analysis
3.3.2. Market restraint analysis
3.4. Cardiovascular Devices Market Analysis Tools
3.4.1. Industry analysis - Porter’s
3.4.1.1. Supplier power
3.4.1.2. Buyer power
3.4.1.3. Substitution threat
3.4.1.4. Threat of new entrant
3.4.1.5. Competitive rivalry
3.4.2. PESTEL analysis
3.4.2.1. Political landscape
3.4.2.2. Technological landscape
3.4.2.3. Economic landscape
Chapter 4. Cardiovascular Devices: Product Estimates & Trend Analysis
4.1. Cardiovascular Devices Market: Key Takeaways
4.2. Cardiovascular Devices Market: Movement & Market Share Analysis, 2022 & 2030
4.3. Diagnostic and Monitoring Devices
4.3.1. Diagnostic and monitoring devices estimates and forecasts, 2018 to 2030 (USD Million)
4.3.1.1. ECG
4.3.1.1.1. ECG market estimates and forecasts, 2018 to 2030 (USD Million)
4.3.1.2. Holter monitors
4.3.1.2.1. Holter monitors market estimates and forecasts, 2018 to 2030 (USD Million)
4.3.1.3. Event monitors
4.3.1.3.1. Event monitors market estimates and forecasts, 2018 to 2030 (USD Million)
4.3.1.4. Implantable loop recorders
4.3.1.4.1. Implantable loop recorders market estimates and forecasts, 2018 to 2030 (USD Million)
4.3.1.5. Echocardiogram
4.3.1.5.1. Echocardiogram estimates and forecasts, 2018 to 2030 (USD Million)
4.3.1.6. Pet scan
4.3.1.6.1. Pet scan market estimates and forecasts, 2018 to 2030 (USD Million)
4.3.1.7. MRI
4.3.1.7.1. MRI market estimates and forecasts, 2018 to 2030 (USD Million)
4.3.1.8. Cardiac CT
4.3.1.8.1. Cardiac CT market estimates and forecasts, 2018 to 2030 (USD Million)
4.3.1.9. Doppler fetal monitors
4.3.1.9.1. Doppler fetal monitors market estimates and forecasts, 2018 to 2030 (USD Million)
4.3.1.10. Cardiac diagnostic catheters
4.3.1.10.1. Cardiac diagnostic catheters market estimates and forecasts, 2018 to 2030 (USD Million)
4.4. Surgical Devices
4.4.1. Surgical devices market estimates and forecasts, 2018 to 2030 (USD Million)
4.4.1.1. Pacemakers
4.4.1.1.1. Pacemakers market estimates and forecasts, 2018 to 2030 (USD Million)
4.4.1.2. Stents
4.4.1.2.1. Stents market estimates and forecasts, 2018 to 2030 (USD Million)
4.4.1.3. Catheters and accessories
4.4.1.3.1. Catheters and accessories market estimates and forecasts, 2018 to 2030 (USD Million)
4.4.1.4. Guidewires
4.4.1.4.1. Guidewires market estimates and forecasts, 2018 to 2030 (USD Million)
4.4.1.5. Cannulae
4.4.1.5.1. Cannulae market estimates and forecasts, 2018 to 2030 (USD Million)
4.4.1.6. Electrosurgical procedures
4.4.1.6.1. Electrosurgical procedures market estimates and forecasts, 2018 to 2030 (USD Million)
4.4.1.7. Valves
4.4.1.7.1. Valves market estimates and forecasts, 2018 to 2030 (USD Million)
4.4.1.8. Occlusion devices
4.4.1.8.1. Occlusion devices market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 5. Cardiovascular Devices Market: Regional Estimates & Trend Analysis
5.1. Regional Outlook
5.2. Cardiovascular Devices Market by Region: Key Marketplace Takeaway
5.3. North America
5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.3.2. U.S.
5.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.3.3. Canada
5.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.4. Europe
5.4.1. UK
5.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.4.2. Germany
5.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.4.3. France
5.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.4.4. Italy
5.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.4.5. Spain
5.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.4.6. Sweden
5.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.4.7. Norway
5.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.4.8. Denmark
5.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.5. Asia Pacific
5.5.1. Japan
5.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.5.2. China
5.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.5.3. India
5.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.5.4. Australia
5.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.5.5. Thailand
5.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.5.6. South Korea
5.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.6. Latin America
5.6.1. Brazil
5.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.6.2. Mexico
5.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.6.3. Argentina
5.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.7. MEA
5.7.1. Saudi Arabia
5.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.7.2. South Africa
5.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.7.3. UAE
5.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.7.4. Kuwait
5.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
Chapter 6. Competitive Landscape
6.1. Recent Developments & Impact Analysis, By Key Market Participants
6.2. Market Participant Categorization
6.2.1. Abbott
6.2.1.1. Company overview
6.2.1.2. Financial performance
6.2.1.3. Product benchmarking
6.2.1.4. Strategic initiatives
6.2.2. GE HealthCare
6.2.2.1. Company overview
6.2.2.2. Financial performance
6.2.2.3. Product benchmarking
6.2.2.4. Strategic initiatives
6.2.3. Edwards Lifesciences Corporation
6.2.3.1. Company overview
6.2.3.2. Financial performance
6.2.3.3. Product benchmarking
6.2.3.4. Strategic initiatives
6.2.4. W. L. Gore & Associates, Inc.
6.2.4.1. Company overview
6.2.4.2. Financial performance
6.2.4.3. Product benchmarking
6.2.4.4. Strategic initiatives
6.2.5. Siemens Healthcare GmbH
6.2.5.1. Company overview
6.2.5.2. Financial performance
6.2.5.3. Product benchmarking
6.2.5.4. Strategic initiatives
6.2.6. BIOTRONIK SE & Co. KG
6.2.6.1. Company overview
6.2.6.2. Financial performance
6.2.6.3. Product benchmarking
6.2.6.4. Strategic initiatives
6.2.7. Canon Medical Systems Asia Pte. Ltd.
6.2.7.1. Company overview
6.2.7.2. Financial performance
6.2.7.3. Product benchmarking
6.2.7.4. Strategic initiatives
6.2.8. B. Braun SE
6.2.8.1. Company overview
6.2.8.2. Financial performance
6.2.8.3. Product benchmarking
6.2.8.4. Strategic initiatives
6.2.9. LivaNova PLC
6.2.9.1. Company overview
6.2.9.2. Financial performance
6.2.9.3. Product benchmarking
6.2.9.4. Strategic initiatives
6.2.10. Cardinal Health
6.2.10.1. Company overview
6.2.10.2. Financial performance
6.2.10.3. Product benchmarking
6.2.10.4. Strategic initiatives
6.2.11. Medtronic
6.2.11.1. Company overview
6.2.11.2. Financial performance
6.2.11.3. Product benchmarking
6.2.11.4. Strategic initiatives
6.2.12. Boston Scientific Corporation
6.2.12.1. Company overview
6.2.12.2. Financial performance
6.2.12.3. Product benchmarking
6.2.12.4. Strategic initiatives

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings